Using artificial intelligence to discover therapeutic antibodies
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advan…
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advan…
Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced the company…
Proteros biostructures GmbH (“Proteros”), an expert in integrated structure-based drug discovery, announces today an exp…
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the deta…
SAP SE (NYSE: SAP) today announced its intent to acquire a majority stake of Taulia, a leading provider of working capit…
According to the National Cancer Institute, cancer survival rates over a five-year period in the US have demonstrated a…
According to the National Cancer Institute, cancer survival rates over a five-year period in the US have demonstrated a…
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/...) announces tha…
S/4HANA Current Cloud Backlog Up 43% At Constant Currencies Highlighting SAP’s Accelerated Cloud Transition IFRS EPS Up…
EXTEDO, a leading provider of regulatory information management (RIM) software and services today announced that they ha…